A Double-Blind, Placebo-Controlled Study of Fluoxetine in Depressed Patients With Alzheimer’s Disease

Abstract

Fluoxetine treatment for depression in AD did not differ significantly from treatment with placebo. Our study also confirms the presence of a placebo effect in the treatment of depression in AD.